Measurable Residual Disease Testing in Multiple Myeloma Routine Clinical Practice: A Modified Delphi Study

We used a modified Delphi approach to establish areas of consensus and nonconsensus regarding the utility of determining measurable residual disease (MRD) to assess multiple myeloma (MM) treatment response, which may inform disease management and design of future clinical trials. This modified Delph...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramasamy, Karthik, Avet-Loiseau, Hervé, Hveding Blimark, Cecilie, Delforge, Michel, Gay, Francesca, Manier, Salomon, Martinez-Lopez, Joaquín, Mateos, Maria Victoria, Mohty, Mohamad, van de Donk, Niels W.C.J., Weisel, Katja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470794/
https://www.ncbi.nlm.nih.gov/pubmed/37663672
http://dx.doi.org/10.1097/HS9.0000000000000942

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470794/
https://www.ncbi.nlm.nih.gov/pubmed/37663672
http://dx.doi.org/10.1097/HS9.0000000000000942

Ejemplares similares